Clinical Isolates of Measles Virus Use CD46 as a Cellular Receptor
- 1 May 2000
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (9), 3967-3974
- https://doi.org/10.1128/jvi.74.9.3967-3974.2000
Abstract
Laboratory strains of measles viruses (MV), such as Edmonston and Halle, use the complement regulatory protein CD46 as a cell surface receptor. The receptor usage of clinical isolates of MV, however, remains unclear. Receptor usage by primary patient isolates of MV was compared to isolates that had been passaged on a variety of tissue culture cell lines. All of the isolates could infect cells in a CD46-dependent manner, but their tropism was restricted according to cell type (e.g., lymphocytes versus fibroblasts). The results indicate that patient isolates that have not been adapted to tissue culture cell lines use CD46 as a receptor. In addition, passaging primary MV patient isolates in B95-8 cells selected variants that had alternate receptor usage compared to the original isolate. Thus, changes in receptor usage by MV are dependent upon the cell type used for isolation. Furthermore, our results confirm the relevance of the CD46 receptor to natural measles infection.Keywords
This publication has 84 references indexed in Scilit:
- Measles Virus Infection in a Transgenic ModelCell, 1999
- Is CD46 the cellular receptor for measles virus?Virus Research, 1997
- Measles: State Of The Art And Future DirectionsThe Journal of Infectious Diseases, 1994
- Measles vaccine: do we need new vaccines or new programs?Science, 1994
- Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46Archiv für die gesamte Virusforschung, 1994
- A Monoclonal Antibody Recognizes a Human Cell Surface Glycoprotein Involved In Measles Virus BindingJournal of General Virology, 1992
- Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene ClusterAnnual Review of Immunology, 1991
- Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassayClinical and Experimental Immunology, 1991
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1931